These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35981542)

  • 1. Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression.
    Sanidas I; Lee H; Rumde PH; Boulay G; Morris R; Golczer G; Stanzione M; Hajizadeh S; Zhong J; Ryan MB; Corcoran RB; Drapkin BJ; Rivera MN; Dyson NJ; Lawrence MS
    Mol Cell; 2022 Sep; 82(18):3333-3349.e9. PubMed ID: 35981542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBF binding to both canonical E2F targets and noncanonical targets depends on functional dE2F/dDP complexes.
    Korenjak M; Anderssen E; Ramaswamy S; Whetstine JR; Dyson NJ
    Mol Cell Biol; 2012 Nov; 32(21):4375-87. PubMed ID: 22927638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.
    Olson BJ; Oberholzer M; Li Y; Zones JM; Kohli HS; Bisova K; Fang SC; Meisenhelder J; Hunter T; Umen JG
    Plant Cell; 2010 Oct; 22(10):3331-47. PubMed ID: 20978220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.
    Johnson JL; Pillai S; Pernazza D; Sebti SM; Lawrence NJ; Chellappan SP
    Cancer Res; 2012 Jan; 72(2):516-26. PubMed ID: 22086850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns in the tapestry of chromatin-bound RB.
    Sanidas I; Lawrence MS; Dyson NJ
    Trends Cell Biol; 2024 Apr; 34(4):288-298. PubMed ID: 37648594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.
    Stengel KR; Thangavel C; Solomon DA; Angus SP; Zheng Y; Knudsen ES
    J Biol Chem; 2009 Jul; 284(29):19265-71. PubMed ID: 19279001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
    Iwahori S; Hakki M; Chou S; Kalejta RF
    J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
    Tyagi A; Agarwal C; Agarwal R
    Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles.
    Liu H; Tang X; Srivastava A; Pécot T; Daniel P; Hemmelgarn B; Reyes S; Fackler N; Bajwa A; Kladney R; Koivisto C; Chen Z; Wang Q; Huang K; Machiraju R; Sáenz-Robles MT; Cantalupo P; Pipas JM; Leone G
    Nat Cell Biol; 2015 Aug; 17(8):1036-48. PubMed ID: 26192440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit composition determines E2F DNA-binding site specificity.
    Tao Y; Kassatly RF; Cress WD; Horowitz JM
    Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.
    Gorges LL; Lents NH; Baldassare JJ
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1151-60. PubMed ID: 18768921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
    Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
    DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.
    Sharon E; Volchek L; Frenkel N
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):451-6. PubMed ID: 24335704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
    Chong JL; Wenzel PL; Sáenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G
    Nature; 2009 Dec; 462(7275):930-4. PubMed ID: 20016602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.